CAMBRIDGE, Mass.--(BUSINESS WIRE)--FORMA Therapeutics and the Experimental Therapeutics Centre of Singapore (ETC) announced today a collaboration agreement to leverage FORMA’s transformative chemistry platform to discover novel compounds for further development by ETC. ETC is funded by the Agency for Science, Technology & Research (A*STAR) of Singapore, which is committed to fostering world-class scientific research and talent for a vibrant, knowledge-based Singapore. Financial terms were not disclosed.
